Reply to Cattoretti: Specificity of anti-MYC antibodies
- PMID: 31924672
- PMCID: PMC6956521
- DOI: 10.1074/jbc.RL119.011997
Reply to Cattoretti: Specificity of anti-MYC antibodies
Conflict of interest statement
The authors declare that they have no conflicts of interest with the contents of this article.
Figures
Comment on
-
Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.J Biol Chem. 2019 Dec 6;294(49):18547-18556. doi: 10.1074/jbc.RA119.009061. Epub 2019 Sep 30. J Biol Chem. 2019. PMID: 31570522 Free PMC article.
-
Specificity of anti-MYC antibodies.J Biol Chem. 2020 Jan 10;295(2):298. doi: 10.1074/jbc.L119.011910. J Biol Chem. 2020. PMID: 31924671 Free PMC article. No abstract available.
References
-
- Shaughnessy J. D. Jr., Largaespada D. A., Tian E., Fletcher C. F., Cho B. C., Vyas P., Jenkins N. A., and Copeland N. G. (1999) Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1. Oncogene 18, 2069–2084 10.1038/sj.onc.1202419 - DOI - PubMed
-
- Tanaka Y., Hysolli E., Su J., Xiang Y., Kim K. Y., Zhong M., Li Y., Heydari K., Euskirchen G., Snyder M. P., Pan X., Weissman S. M., and Park I. H. (2015) Transcriptome signature and regulation in human somatic cell reprogramming. Stem Cell Reports 4, 1125–1139 10.1016/j.stemcr.2015.04.009 - DOI - PMC - PubMed
-
- Im I., Son Y. S., Jung K. B., Kang I., Teh B-e Lee K-B, Son M.-Y., and Kim J. (2019) Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers. J. Biol. Chem. 294, 18547–18556 10.1074/jbc.RA119.009061 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources